
    
      In order to exclude an inductive effect of selexipag in the gastrointestinal tract, this
      study aims at investigating the effect of selexipag on the PK of midazolam, a sensitive
      substrate of both hepatic and intestinal cytochrome P450 3A4 (CYP3A4).
    
  